Rancho Research Institute, Inc
Downey, California, 90242, United States
Location status: Recruiting
NCT Number: NCT06752707
This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Downey, California, 90242, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Perform home exercise sessions while wearing MiGo Tracker device that logs exercise data.
Exercise following printed sheets or booklet
Time frame: Baseline and 3 months post stroke
The Fugl-Meyer Assessment - Upper Extremity (FMA-UE) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, sensation, balance, joint range of motion and joint pain in patients with post-stroke hemiplegia. A standardized assessment of arm impairment based on scores of 0-2 on 33 different tasks. Minimum value = 0, maximum value = 66, higher scores = better outcome
Time frame: Baseline and 3 months post stroke
The Action Research Arm Test (ARAT) is a 19-item measure aimed at assessing functional performance of the upper extremity through observational means. The ARAT is a 19 item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from:
(3) Performs test normally (2) Completes test, but takes abnormally long or has great difficulty
(1) Performs test partially (0) Can perform no part of test
Time frame: Baseline and 3 months post stroke
The Box and Block Test assesses unilateral gross manual dexterity. The test is scored by counting the number of blocks carried over the partition from one compartment to the other during the one-minute trial period.
Time frame: Baseline and 3 months post stroke
The MAL is a semi-structured interview to assess arm function. Individuals are asked to rate Quality of Movement (QOM) and Amount of Movement (AOM) during 30 daily functional tasks. Items scored on a 6-point ordinal scale.
Scoring on Amount of Use Scale: 0) The weaker arm was not sued at all for that activity (never) 1) very rarely 2) rarely 3) half pre-stroke 4)3/4 pre-stroke 5) normal. Quality of Movement Scale: 0) The weaker arm was not used at all for that activity (never) 1) very poor 2) poor 3) fair 4) almost normal 5) normal
Time frame: Baseline and 3 months post stroke
MAS is an assessment that is used to measure the increase in muscle tone. MAS assigns a grade of spasticity from a 0-4 ordinal scale. The grade is assigned by moving a joint/muscle through a high velocity quick stretch. A score of 1 indicates no resistance, and 5 indicates rigidity.
Time frame: Baseline and 3 months post stroke
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10cm line that represents a continuum between "no pain" and "worst pain".
Contact information is provided by the study sponsor or research team.
Daniel Zondervan, PhD
CONTACT
Ian M Russell, PhD
CONTACT
Flint Rehabilitation Devices, LLC
Industry
MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07469163
Brain Diseases, Cardiovascular Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT07236216
Brain Diseases, Cardiovascular Diseases
Nakhon Pathom, Thailand
View Trial DetailsNCT06972355
Brain Diseases, Cardiovascular Diseases
Metz, France
View Trial DetailsNCT06927206
Brain Diseases, Cardiovascular Diseases
Lahore, Punjab Province, Pakistan
View Trial Details